This 2-year-old was born deaf. Now he can hear thanks to a new gene therapy

Otarmeni, a surgically-delivered drug developed by Regeneron, recently received accelerated FDA approval to treat a rare, genetic hearing condition.

Raccontata daeu.usatoday.com